Canada’s Leading Research Universities

Developing talent, Driving innovation, Delivering impact.

Getty Images

Q and A with the experts: AstraZeneca and viral vector vaccines

Posted onApril 12, 2021

The AstraZeneca vaccine has recently been approved in Canada and is evaluated to be about 62 per cent effective in preventing the COVID-19 virus.

Kelly Grindrod, a pharmacist and professor, breaks down how this vaccine and others like it work.

https://uwaterloo.ca/news/media/q-and-experts-astrazeneca-and-viral-vector-vaccines

Read More Impact Stories

Posted onMarch 21, 2024
This article is only available in French. Lésion de la moelle épinière: stimuler la plasticité des neurones pour améliorer la [...]
Posted onJanuary 24, 2024
A comprehensive study by scientists at UdeM maps the evolutionary dynamics and risks of viral emergence of diseases that could [...]
Posted onJanuary 24, 2024
This article is available only in French. Infections respiratoires: mieux trier les patients pour soulager la pression sur les urgences [...]